Compare products Close window [X]

Dihydro Artemisinin Dimer is chemically (3R,3’R,5aS,5a’S,6R,6’R,8aS,8a’S,9R,9’R,10S,10’S,12R,12aR,12’R,12a’R)-10,10′-oxybis(3,6,9-trimethyldecahydro-12H-3,12-epoxy[1,2]dioxepino[4,3-i]isochromene).
Dihydro Artemisinin Dimer is supplied with detailed characterization data compliant with regulatory guideline. Dihydro Artemisinin Dimer can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Artemisinin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ISP Standards products are for analytical purpose only and not for human use.

Betamethasone Impurity 11 is chemically Ethyl (E)-2-((9R,10S,11S,13S,16S)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-3,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-17H-cyclopenta[a]phenanthren-17-ylidene)acetate.
Betamethasone Impurity 11 is supplied with detailed characterization data compliant with regulatory guideline. Betamethasone Impurity 11 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Betamethasone.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ISP Standards products are for analytical purpose only and not for human use.

Lacosamide Impurity C is chemically 1,3-Dibenzylurea.
Lacosamide Impurity C is supplied with detailed characterization data compliant with regulatory guideline. Lacosamide Impurity C can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lacosamide.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ISP Standards products are for analytical purpose only and not for human use.